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Abstract
© 2017 American Chemical  Society.  Deep generative adversarial  networks (GANs) are the
emerging technology in drug discovery and biomarker development. In our recent work, we
demonstrated a proof-of-concept  of  implementing deep generative adversarial  autoencoder
(AAE) to identify new molecular fingerprints with predefined anticancer properties.  Another
popular generative model is the variational autoencoder (VAE), which is based on deep neural
architectures.  In  this  work,  we  developed  an  advanced  AAE  model  for  molecular  feature
extraction  problems,  and  demonstrated  its  advantages  compared  to  VAE  in  terms  of  (a)
adjustability  in  generating  molecular  fingerprints;  (b)  capacity  of  processing  very  large
molecular data sets; and (c) efficiency in unsupervised pretraining for regression model. Our
results suggest that the proposed AAE model significantly enhances the capacity and efficiency
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